KfW is a German state-owned development bank.
Business Model:
Revenue: $3.1B
Employees: 5,001-10,000
Address: Palmengartenstrasse 5-9
City: Frankfurt am Main
State: hesse
Zip: 60325
Country: DE
KfW gives impetus to economic, social and ecological development worldwide. As a promotional bank under the ownership of the Federal Republic and the Länder (federal states), it offers support to encourage sustainable improvement in economic, social, ecological living and business conditions, among others in the areas of small and medium-sized enterprise, entrepreneurialship, environmental protection, housing, infrastructure, education finance, project and export finance, and development cooperation.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
7/2020 | kraftwerk TUBES GmbH | Convertible Note | 562.6k |
6/2015 | Minodes | Seed Round | 1.4M |
5/2010 | Caprotec Bioanalytics | Series B | 5.1M |
5/2008 | locr | Angel Round | 1.7M |
7/2008 | Biontis | Venture Round | - |
4/2013 | miacosa | Venture Round | - |
5/2006 | SuppreMol | Series A | 0 |
12/2011 | Zitra.com | Seed Round | - |
1/2008 | Cytocentrics | Venture Round | 1.4M |
3/2015 | GNA Biosolutions | Series B | 0 |
2/2015 | rankingCoach | Venture Round | - |
9/2010 | Phenex Pharmaceuticals | Series C | 0 |
11/2015 | aquila biolabs | Seed Round | - |
7/2006 | t2cure | Series A | - |
2/2011 | SAW Instruments | Series B | 1.4M |
10/2013 | Schutzklick | Venture Round | - |
6/2020 | CureVac | Venture Round | 340.2M |
2/2012 | numares HEALTH | Venture Round | 9.5M |
9/2011 | apprupt | Series B | - |
10/2015 | NEUWAY Pharma | Series A | 3.5M |
11/2010 | Placetel | Private Equity Round | - |
3/2011 | clickworker | Series B | 6M |
3/2010 | clickworker | Series A | 0 |
9/2007 | Emporis | Venture Round | - |
2/2011 | INCHRON | Venture Round | - |
10/2010 | Zimory | Venture Round | 5.5M |
10/2011 | Humedics | Series A | - |
11/2018 | OMEICOS Therapeutics | Series C | 0 |
12/2010 | SuppreMol | Series C | 20.4M |
7/2017 | Hemovent | Series A | 2.3M |
1/2008 | Protagen | Venture Round | 1.5M |
3/2006 | Micropelt | Series A | 6M |
5/2012 | Micropelt | Venture Round | 8.5M |
12/2015 | meventi Deutschland | Venture Round | - |
12/2016 | amcure | Series B | 6.3M |
10/2006 | numares HEALTH | Venture Round | 2.5M |
2/2017 | smartB | Series A | - |
1/2014 | smartB | Series A | 5.4M |
9/2015 | Biametrics GmbH | Series A | 3.5M |
11/2008 | OXID eSales | Venture Round | - |
6/2018 | IL&a;FS Transportation Networks | Post-IPO Debt | 27.6M |
12/2015 | Trinckle | Seed Round | 0 |
9/2012 | Orpheus GmbH | Seed Round | - |
8/2013 | CorTec | Series A | 4M |
12/2012 | clickworker | Venture Round | 0 |
3/2022 | HelloDuty | Grant | 111.3k |
9/2007 | Galantos Pharma | Series B | 3.8M |
10/2012 | Zalando | Debt Financing | 52.6M |
9/2012 | GOVECS | Venture Round | 12.6M |
6/2011 | Cynora | Series A | 6.6M |
1/2022 | Electrochaea | Series D | 0 |
10/2012 | avandeo | Venture Round | - |
5/2010 | apprupt | Series A | - |
7/2021 | InsuResilience Investment Fund | Grant | 53.2M |
3/2013 | SIRION BIOTECH | Venture Round | - |
1/2015 | Shelter Afrique | Debt Financing | 50M |
8/2009 | Protagen | Venture Round | 5.3M |
3/2006 | VERTILAS | Series C | 4.3M |
6/2011 | Vimecon | Venture Round | - |
10/2009 | Nevigo (Articy) | Private Equity Round | - |
11/2009 | ELARA Pharmaceuticals | Series A | 6.9M |
9/2009 | Stream5 | Venture Round | - |
7/2006 | Art of Defence | Series A | 2.9M |
8/2013 | Capical GmbH | Series A | - |
11/2014 | Electrochaea | Series A | - |
10/2018 | pflege.de | Venture Round | 0 |
2/2016 | Hemovent | Series A | 6M |
3/2011 | bettermarks | Venture Round | 4.2M |
3/2016 | nello | Seed Round | 760.6k |
6/2011 | NonWoTecc Medical | Series B | 10.1M |
5/2010 | bettermarks | Venture Round | 6.1M |
4/2014 | Streetspotr | Seed Round | - |
7/2016 | Arzneimittelwerk Warngau | Series C | 6.6M |
9/2010 | VIOSO | Series B | 401.6k |
9/2015 | Datapine | Series A | 0 |
11/2015 | Cleverciti | Seed Round | 0 |
3/2017 | OMEICOS Therapeutics | Series B | 0 |
12/2008 | Lieferando | Seed Round | - |
9/2018 | Veact | Series B | - |
9/2008 | QuinLogic | Seed Round | 2.3M |
11/2008 | Ubitexx | Series B | 1.9M |
1/2011 | sones | Series A | - |
9/2011 | Sividon Diagnostics | Private Equity Round | - |
8/2012 | evidanza | Series C | 5.1M |
10/2020 | Cleverciti | Series A | 0 |
1/2014 | pflege.de | Series A | 1.6M |
1/2009 | Novaled | Series C | 0 |
4/2022 | Polygenta Technologies | Debt Financing | 0 |
5/2018 | Implandata Ophthalmic Products | Series C | - |
2/2010 | Cuculus | Series B | 0 |
7/2005 | Art of Defence | Venture Round | 359k |
2/2021 | GetYourGuide | Debt Financing | 0 |
6/2013 | Serfides | Seed Round | 2.6M |
7/2010 | locr | Venture Round | - |
6/2014 | meventi Deutschland | Venture Round | - |
6/2018 | Eskom Holdings | Debt Financing | 100M |
4/2015 | Eskom Holdings | Debt Financing | 339M |
10/2005 | Phenex Pharmaceuticals | Series A | 5M |
4/2020 | Adidas | Post-IPO Debt | - |
10/2014 | Implandata Ophthalmic Products | Series B | 0 |
11/2008 | VIOSO | Series A | 1.3M |
1/2008 | DIVOLUTION | Venture Round | - |
10/2011 | numares HEALTH | Venture Round | 9.5M |
5/2007 | KINAXO Biotechnologies | Series A | - |
8/2008 | Signature Diagnostics GmbH | Series C | 7.6M |
2/2013 | Orpheus GmbH | Series A | - |
8/2008 | Protagen | Venture Round | - |
7/2012 | Customer Alliance | Series B | - |
12/2009 | numares HEALTH | Venture Round | 5.7M |
2/2013 | ZooRoyal | Venture Round | - |
4/2011 | OctreoPharm Sciences | Venture Round | 7.2M |
5/2005 | Sloning BioTechnology | Series C | 3.9M |
8/2015 | 8select | Seed Round | 1.5M |
3/2021 | Productsup | Debt Financing | 0 |
8/2020 | EFTA | Venture Round | 0 |
4/2009 | KeyNeurotek Pharmaceuticals | Series C | 10.9M |
6/2021 | Electrochaea | Venture Round | - |
10/2008 | Phenex Pharmaceuticals | Series B | 11.4M |
8/2005 | Hyglos | Series C | 0 |
4/2017 | nello | Seed Round | 1.6M |
6/2013 | Pactas GmbH | Venture Round | - |
5/2014 | Tixxt | Venture Round | - |
5/2011 | Protectimmun GmbH | Seed Round | - |
5/2008 | studdex | Angel Round | 278.5k |
5/2012 | simplesurance | Seed Round | - |
2/2011 | FAIRRANK GmbH | Venture Round | - |
2/2009 | sofatronic | Series B | - |
12/2016 | Acousia Therapeutics | Series A | 0 |
9/2012 | Augmentation Industries | Seed Round | 1.9M |
1/2022 | Uniper | Post-IPO Debt | 0 |
4/2009 | Metasonic AG | Venture Round | - |
11/2007 | Sloning BioTechnology | Series E | 6.8M |
11/2016 | DiGiConsul | Debt Financing | - |
9/2009 | Sloning BioTechnology | Venture Round | - |
6/2015 | Mandulis Energy | Grant | 170k |
12/2021 | NamPower | Grant | 0 |
9/2010 | GreenPocket | Series A | 2.1M |
1/2012 | Intelligent Apps | Series B | 13M |
8/2009 | CorporateWorld | Series B | - |
2/2016 | readfy | Seed Round | - |
12/2011 | pflege.de | Venture Round | - |
5/2010 | Galantos | Series C | 5.7M |
12/2005 | Novaled | Series B | 0 |
12/2010 | Blue Lion Mobile (QEEP) | Series B | - |
12/2009 | Curetis | Series A | 27.9M |
6/2006 | Innolume | Series B | 9M |
1/2007 | Voipfuture | Seed Round | - |
4/2017 | BigRep | Series B | 15M |
12/2014 | WeSustain | Series B | 0 |
6/2006 | NanoCompound | Series B | 1.9M |
11/2012 | RegioHelden | Series A | - |
5/2016 | Unidesq | Seed Round | - |
1/2014 | flinc GmbH | Venture Round | - |
7/2014 | AYOXXA | Series B | 12.1M |
11/2015 | Sicoya | Series A | 3.8M |
11/2007 | INCHRON | Venture Round | - |
6/2011 | SIRION BIOTECH | Venture Round | - |
5/2018 | advanceCOR | Venture Round | 7.1M |
5/2018 | Acousia Therapeutics | Series B | 0 |
5/2012 | Algiax Pharmaceuticals | Series A | 5.5M |
7/2008 | SuppreMol | Series B | 25M |
10/2015 | Veact | Series A | 3M |
11/2009 | Confovis | Seed Round | - |
7/2016 | fromAtoB | Series A | 10.5M |
7/2014 | predict.io | Seed Round | 680.3k |
8/2019 | GNA Biosolutions | Series C | 0 |
11/2015 | BigRep | Series A | 0 |
2/2007 | immatics biotechnologies | Series B | 52.1M |
7/2012 | Subitec | Series B | 5.5M |
7/2011 | Pay by Shopping (deal united) | Series B | - |
12/2010 | ubigrate | Series B | - |
4/2015 | OMEICOS Therapeutics | Series A | 0 |
3/2011 | intelligent fluids GmbH | Series B | 1.7M |
7/2016 | CryoTherapeutics | Series B | 0 |
1/2011 | GILUPI | Series C | 0 |
4/2022 | Polygenta Technologies | Debt Financing | 0 |
1/2022 | Electrochaea | Series D | 0 |
1/2022 | Uniper | Post-IPO Debt | 0 |
12/2021 | NamPower | Grant | 0 |
7/2021 | InsuResilience Investment Fund | Grant | 0 |
6/2021 | Electrochaea | Venture Round | - |
3/2021 | Productsup | Debt Financing | 0 |
2/2021 | GetYourGuide | Debt Financing | 0 |
10/2020 | Cleverciti | Series A | 0 |
8/2020 | EFTA | Venture Round | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|